[1]Zhou Z, Wang S, Song C, et al. Paeoniflorin prevents hypoxia-induced epithelial-mesenchymal transition in human breast cancer cells[J].Onco Targets Ther, 2016, 9(1): 2511-2518.
[2]Zhang HW, Zhang BG, Song R H, et al. Effect of Raptor on invasion ability of glioma cells [J].Chinese Journal of Pathophysiology, 2014, 30(12):2280-2283. (in Chinese)
张洪旺,张宝刚,宋瑞卉,等. Raptor对胶质瘤细胞侵袭能力的影响[J]. 中国病理生理杂志,2014, 30(12):2280-2283.
[3]Li XL, Qi YL, Chen WY, et al.. Disruption of Raptor by using RNA interference influences the invasiveness of human breast cancer cells and it’s relative mechanism [J].Chinese Journal of Cancer Prevention and Treatment, 2014,21(22):1764-1768. (in Chinese)
李小龙,齐岳亮,陈为一,等. 下调Raptor表达对乳腺癌细胞侵袭能力影响及其机制探讨[J]. 中华肿瘤防治杂志,2014,21(22):1764-1768.
[4]Li H, Zhang B, Liu Y, et al. EBP50 inhibits the migration and invasion of human breast cancer cells via LIMK/cofilin and the PI3K/Akt/mTOR/MMP signaling pathway[J]. Med Oncol, 2014, 31(9):162.
[5]Yin C, Li H, Zhang B, et al. RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition[J]. Breast Cancer Res Treat, 2013,142(2):297-309.
[6]Li T, Xie J, Shen C, et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma[J].Oncogene, 2016, 35(12):1578-1584.
[7]Zhang LM, Zhan J, Zhang HQ, et al. Identification of the downstream signaling pathways of HOXAS in breast cancer cells[J]. Acta Anatomica Sinia, 2015,(5):634-640. (in Chinese)张立美,战军,张宏权,等. 转录因子HOXA5在乳腺癌细胞中的下游信号通路[J]. 解剖学报,2015,(5):634-640.
[8]Wen J, Luo KJ, Liu QW, et al. The epithelial-mesenchymal transition phenotype of metastatic lymph nodes impacts the prognosis of esophageal squamous cell carcinoma patients[J]. Oncotarget, 2016, 7(25):37581-37588.
[9]Foster KG, Acosta-jaquez HA, Romeo Y, et al. Regulation of mTOR Complex 1 (m TORC1) by Raptor Ser863 and Multisite Phosphorylation[J]. J Bio Chem, 2010, 285(1):80-94.[10]Gupta M, Hendrickson AE, Yun SS, et al. Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Pumadependent apoptosis in lymphoid malignancies[J]. Blood, 2012,119(2):476-487.
[11]Yin L, Gao Y, Zhang X, et al. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling[J]. Oncotarget, 2016, 7(27):42126-42138.
[12]Park JH, Kwon HY, Sohn EJ, et al. Inhibition of Wnt/β-catenin signaling mediates ursolic acid-induced apoptosis in PC-3 prostate cancer cells [J]. Pharmacol Rep,2013, 65(5):1366-1374.
[13]Lalefar NR, Witkowski A, Simonsen JB, et al. Wnt3a nanodisks promote ex vivo expansion bof hematopoietic stem and progenitor cells[J]. J Nanobiotechnology, 2016, 14(1):66.[14] Seo DK, Kim JH, Min J, et al. Enhanced axonal regeneration by transplanted Wnt3a-secreting human mesenchymal stem cells in a rat model of spinal cord injury[J]. Acta Neurochir (Wien), 2017, 159(5): 947-957.
[15]Tseng JC, Lin CY, Su LC, et al. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling[J]. Oncotarget, 2016, 7(25):38010-38024.
[16]Yu J, Huang Y, Liu L, et al. Genetic polymorphisms of Wnt/β-catenin pathway genes are associated with the efficacy and toxicities of radiotherapy in patients with nasopharyngeal carcinoma [J]. Oncotarget, 2016,7(50):82528-82537.
[17]Schirosi L, Mazzotta A, Opinto G, et al. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients[J]. Oncotarget, 2016, 7(42):67841-67850.
|